Key result
Nonagenarian women with STEMI linked to ~38% lower odds of PCI vs men despite survival benefit.
Why the study?
Acute coronary syndrome remains a leading cause of mortality in women, yet an unmet need persists regarding its management and long-term outcomes in nonagenarians.
Does female sex affect the rate of invasive management and 1-year survival in nonagenarians with acute coronary syndrome?
Cohort (n=680)
Yes
Does female sex affect the rate of invasive management and 1-year survival in nonagenarians with acute coronary syndrome?
Odds Ratio: 0.62 (95% CI 0.38–0.97)
Absolute Event Rate: 45% vs 60%
p-value: p=0.03
Highlights a significant sex disparity where nonagenarian women receive less invasive acute coronary syndrome management than men, despite deriving a greater 1-year survival benefit from revascularization.
Observed lower PCI rates in nonagenarian women with STEMI should not change practice; leaves open confirmation of greater survival benefit in prospective studies.
BACKGROUND: Acute coronary syndrome (ACS) remains one of the leading causes of mortality for women, increasing with age. There is an unmet need regarding this condition in a fast-growing and predominantly female population, such as nonagenarians. HYPOTHESIS: Our aim is to compare sex-based differences in ACS management and long-term clinical outcomes between women and men in a cohort of nonagenarians. METHODS: We included consecutive nonagenarian patients with ACS admitted at four academic centers between 2005 and 2018. The study was approved by the Ethics Committee of each center. RESULTS: A total of 680 nonagenarians were included (59% females). Of them, 373 (55%) patients presented with non-ST-segment elevation ACS and 307 (45%) with ST-segment elevation myocardial infarction (STEMI). Men presented a higher disease burden compared to women. Conversely, women were frailer with higher disability and severe cognitive impairment. In the STEMI group, women were less likely than men to undergo percutaneous coronary intervention (PCI) (60% vs. 45%; p = .01). Overall mortality rates were similar in both groups but PCI survival benefit at 1-year was greater in women compared to their male counterparts (82% vs. 68%; p = .008), persisting after sensitivity analyses using propensity-score matching (80% vs. 64%; p = .03). CONCLUSION: Sex-gender disparities have been observed in nonagenarians. Despite receiving less often invasive approaches, women showed better clinical outcomes. Our finding may help increase awareness and reduce the current gender gap in ACS management at any age.
No takes yet. Share an insight, caveat, or question.
Cepas‐Guillén et al. (2021) conducted a cohort in Acute coronary syndrome (ACS) (n=680). Female sex vs. Male sex was evaluated on Undergoing percutaneous coronary intervention (PCI) in STEMI (OR 0.62, 95% CI 0.38-0.97, p=0.03). Nonagenarian women with STEMI were significantly less likely to undergo percutaneous coronary intervention compared to men (OR 0.62), despite demonstrating a greater 1-year survival benefit from the procedure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: